Literature DB >> 20130377

The incidence, intensity and host morbidity of human parasitic protozoan infections in gastrointestinal disorder outpatients in Buea Sub Division, Cameroon.

Judith Veshiyi Mbuh1, Helen N Ntonifor, James T Ojong.   

Abstract

BACKGROUND: Numerous protozoans inhibit the gastrointestinal tract of humans with the majority being either non-pathogenic commensals or of a type that may result in mild disease. However, some of these organisms can cause severe diseases under certain circumstances while others may become highly virulent and invasive causing potentially lethal systemic disease. This study investigated the prevalence, intensity and host morbidity of human intestinal protozoan infections in individuals living in the Buea Sub-Division, Cameroon.
METHODOLOGY: Random sampling was used to collect stool samples from 356 patients in a cross-sectional study. All samples were examined by formol-ether concentration and direct smear techniques. Data collected was analyzed and differences in proportions were determined using the Chi square (chi(2)) test, Fisher's exact test, or analysis of variance where appropriate.
RESULTS: It was found that 28.1% (100/356) of the sampled population were infected with protozoans. Females showed a higher infection rate (29.7%; 56/182) than males (26.4%; 46/174) and there was a significantly (P < 0.001) higher prevalence in rural areas (38.7%; 55/142) than in urban areas (21.0%; 45/214). The 6 to 12 years age group had a significantly (P < 0.05) higher infection rate (42.9%; 30/70). The total prevalence of intestinal protozoans was as follows: E. histolytica (24.4%), E. coli (11.2%) and G. lamblia (0.6%). The most prevalent morbidity effects associated with intestinal protozoan infections were abdominal pains, dysentery and body weakness.
CONCLUSIONS: Since human intestinal parasitic infections are high in the study area, mass treatment of people with intestinal protozoans is strongly recommended, especially in the rural areas where the prevalence was very high.

Entities:  

Mesh:

Year:  2009        PMID: 20130377     DOI: 10.3855/jidc.82

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Prevalence, characteristics and correlates of enteric pathogenic protozoa in drinking water sources in Molyko and Bomaka, Cameroon: a cross-sectional study.

Authors:  Fuh Anold Nsoh; Buh Amos Wung; Julius Atashili; Pokam Thumamo Benjamin; Eba Marvlyn; Keumami Katte Ivo; Assob Jules Clément Nguedia
Journal:  BMC Microbiol       Date:  2016-11-08       Impact factor: 3.605

2.  Intestinal parasitosis and anaemia among patients in a Health Center, North Ethiopia.

Authors:  Megbaru Alemu; Birhane Kinfe; Desalegn Tadesse; Wondemagegn Mulu; Tadesse Hailu; Endalew Yizengaw
Journal:  BMC Res Notes       Date:  2017-11-28

3.  Prevalence and Risk Factors Associated with Intestinal Parasitic Infection among Primary School Children in Dera District, Northwest Ethiopia.

Authors:  Dires Tegen; Destaw Damtie
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-09-21       Impact factor: 2.471

4.  Prevalence of intestinal parasitic infections in Hawassa University students' clinic, Southern Ethiopia: a 10-year retrospective study.

Authors:  Tadesse Menjetta; Teketel Simion; Wondimu Anjulo; Kidist Ayele; Mekides Haile; Tewodros Tafesse; Solomon Asnake
Journal:  BMC Res Notes       Date:  2019-10-28

5.  The immunoglobulin G antibody response to malaria merozoite antigens in asymptomatic children co-infected with malaria and intestinal parasites.

Authors:  Crespo'o Mbe-Cho Ndiabamoh; Gabriel Loni Ekali; Livo Esemu; Yukie Michelle Lloyd; Jean Claude Djontu; Wilfred Mbacham; Jude Bigoga; Diane Wallace Taylor; Rose Gana Fomban Leke
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

6.  Gastrointestinal Nematodes among Residents in Melong, Moungo Division, Littoral Region, Cameroon.

Authors:  Yamssi Cedric; Noumedem Anangmo Christelle Nadia; Vincent Khan Payne; M Sabi Bertrand; Ngangnang Ghislain Romeo
Journal:  Biomed Res Int       Date:  2021-02-09       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.